MedTrace Logo

Misoprostol Versus Dilapan-S for Cervical Preparation

NCT00835731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2017-10-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.

Conditions

  • Cervical Ripening

Interventions

DRUG

misoprostol

400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D\&E

DEVICE

Dilapan-S, vitamin B-12

One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D\&E. Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D\&E

Sponsors & Collaborators

Principal Investigators

  • Prinicpal Investigator · Planned Parenthood League of Massachusetts

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835731 on ClinicalTrials.gov